11
views
0
recommends
+1 Recommend
2 collections
    0
    shares

      Jaypee Content relevant to SDG 03 - Good Health & Wellbeing. To subscribe to Jaypee Journals, please click here

      Want to submit a manuscript? Please click here for Instructions

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Coronary Microaneurysms—An Early Manifestation of Kawasaki Disease: A Case Report

      case-report
      Pediatric Infectious Disease
      Jaypee Brothers Medical Publishers
      Coronary artery aneurysm, Kawasaki, Kawasaki disease, Pediatric

      Read this article at

      ScienceOpenPublisher
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Introduction

          Kawasaki disease (KD) is a medium-vessel vasculitis with a predilection for coronary arteries and has been recognized to be the most common cause of acquired heart disease in children (Hedrich et al., 2018; Newburger et al., 2016; Saguil et al., 2015; Singh et al., 2018; Sundel, 2015). Hedrich et al. (2018) outline how coronary artery aneurysms are a typical manifestation of KD that develops after several weeks of disease.

          Case presentation

          This case report describes the clinical course and outcomes of a patient, a 5-year-old Hispanic female with KD who displayed early development of coronary microaneurysms as opposed to the typical late sequelae development.

          Discussion and conclusion

          This unique presentation of KD highlights some crucial questions that should be addressed, including whether coronary artery aneurysms should be reconsidered as only a late sequela of untreated disease. Can coronary artery aneurysms be an early manifestation of KD?

          How to cite this article

          Godin SL. Coronary Microaneurysms—An Early Manifestation of Kawasaki Disease: A Case Report. Pediatr Inf Dis 2023;5(2):49-51.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Kawasaki Disease.

          Kawasaki disease is an acute, self-limited vasculitis of unknown etiology that occurs predominantly in infants and children. If not treated early with high-dose intravenous immunoglobulin, 1 in 5 children develop coronary artery aneurysms; this risk is reduced 5-fold if intravenous immunoglobulin is administered within 10 days of fever onset. Coronary artery aneurysms evolve dynamically over time, usually reaching a peak dimension by 6 weeks after illness onset. Almost all the morbidity and mortality occur in patients with giant aneurysms. Risk of myocardial infarction from coronary artery thrombosis is greatest in the first 2 years after illness onset. However, stenosis and occlusion progress over years. Indeed, Kawasaki disease is no longer a rare cause of acute coronary syndrome presenting in young adults. Both coronary artery bypass surgery and percutaneous intervention have been used to treat Kawasaki disease patients who develop myocardial ischemia as a consequence of coronary artery aneurysms and stenosis.
            • Record: found
            • Abstract: found
            • Article: not found

            Kawasaki Disease: an Update

            Purpose of Review Provide the most recent updates on the epidemiology, pathogenesis, and treatment advances in Kawasaki disease. Recent Findings Treatment advances in complex, IVIG-refractory cases of Kawasaki disease. Multisystem inflammatory syndrome, a newly reported inflammatory condition with Kawasaki-like features and an association with the 2019 Coronavirus (COVID-19). Summary Kawasaki disease (KD) is a rare systemic inflammatory disease that predominately affects children less than 5 years of age. Pathogenesis of KD remains unknown; the leading theory is that an unknown stimulus triggers an immune-mediated inflammatory cascade in a genetically susceptible child. Classic KD is a clinical diagnosis based on set criteria and excluding other similar clinical entities. Patients who do not fulfill complete diagnostic criteria for KD are often referred to as atypical (or incomplete) KD. The most feared complication of KD is coronary artery abnormality development, and patients with atypical KD are also at risk. Administration of intravenous immunoglobulin (IVIG) and aspirin has greatly reduced the incidence of coronary lesions in affected children. Several other immune-modulating therapies have recently been utilized in complex or refractory cases.
              • Record: found
              • Abstract: found
              • Article: not found

              Diagnosis of Kawasaki disease

              Abstract Kawasaki disease (KD) is a medium vessel vasculitis with predilection for coronary arteries. Due to lack of a reliable confirmatory laboratory test, the diagnosis of KD is based on a constellation of clinical findings that appear in a typical temporal sequence. These diagnostic criteria have been modified from time to time and the most recent guidelines have been proposed by the American Heart Association (AHA) in 2017. However, several children may have incomplete or atypical forms of KD and the diagnosis can often be difficult, especially in infants and young children. In this review, we have detailed the steps involved in arriving at a diagnosis of KD and also highlight the important role of echocardiography in diagnosis and management of children with KD.

                Author and article information

                Contributors
                Journal
                PID
                Pediatric Infectious Disease
                PID
                Jaypee Brothers Medical Publishers
                2582-4988
                April-June 2023
                : 5
                : 2
                : 49-51
                Affiliations
                [1]South Texas Health System, Edinburg, Texas, United States
                Author notes
                Shea-Lee Godin, South Texas Health System, Edinburg, Texas, United States, Phone: (708) 916-6600, e-mail: sgodin@ 123456mail.sjsm.org
                Article
                10.5005/jp-journals-10081-1377
                bc34d96d-c0eb-4f12-b2ea-ccf2b7b772cc
                Copyright © 2023; The Author(s).

                © The Author(s). 2023 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 27 May 2022
                : 16 October 2022
                : 30 June 2023
                Categories
                CASE REPORT
                Custom metadata
                pid-05-049.pdf

                Pediatrics
                Kawasaki disease,Coronary artery aneurysm,Pediatric,Kawasaki
                Pediatrics
                Kawasaki disease, Coronary artery aneurysm, Pediatric, Kawasaki

                Comments

                Comment on this article

                Related Documents Log